Study of NTB-928 in R/R OC

NCT07690189 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed/Refractory Ovarian Carcinoma

Interventions

DRUG: NTB-928

Sponsor

TeneoSeven, Inc.